|
CN104713981A
|
|
Content calculation method of 2,4-dichloro-3-nitro-5-fluorobenzoyl chloride generated by acylation reaction
|
|
CN104043621A
|
|
Cleaning method for gas-phase or liquid-phase sample injection small bottle
|
|
CN104045514A
|
|
Synthetic method for 2-butyne-1-ol
|
|
CN104163827A
|
|
Synthetic method of sodium beta-glycerophosphate
|
|
CN104045561A
|
|
Synthetic method for 3,3,5-trimethylcyclohexanol salicylate
|
|
CN104049045A
|
|
Gas phase needle maintenance method for high-viscosity or high-freezing point substances
|
|
CN104198596A
|
|
Detection method of solvent residue in sodium propylthiouracil salt
|
|
CN104163756A
|
|
Synthetic method of 2-hydroxy-4-methoxybenzophenone
|
|
CN104193616A
|
|
A synthetic method of 2-chloro-5-iodobenzoic acid
|
|
CN103506133A
|
|
Anti-dehalogenation Pd-Fe/C catalyst for preparing halogen aniline and preparation method of same
|
|
CN103508932A
|
|
Method for synthesizing diabetes drug-glimepiride
|
|
CN103508879A
|
|
Synthesis method of halogenated alkoxyl acetic acid
|
|
CN103524332A
|
|
Synthesis method of 2-[2-(2-methoxyethoxy) ethoxy] acetic acid
|
|
CN103601661A
|
|
Synthetic method for II-type diabetes medicine glimepiride by using triphosgene
|
|
CN103497111A
|
|
Synthetic method for 2, 3, 4-trifluoroaniline
|
|
CN103483203A
|
|
Synthesis method of 2,4-dichloro-3-nitro-5-fluorobenzoic acid carbonic oxide
|
|
CN103483145A
|
|
Improved synthesis method of dichlorofluorobenzene
|
|
CN103420874A
|
|
Synthesis method of key intermediate isocyanate of hypoglycemic medicine
|
|
CN103304422A
|
|
Synthesis method for 2,4-dichloro-3-nitro-5-fluorobenzoic acid
|
|
CN102875527A
|
|
Preparation method of desloratadine
|
